Allyx Therapeutics Announces License For The Treatment of Cognitive Deficits in Neurodegenerative Disorders From Bristol Myers Squibb And Yale
Term Sheet Recommendations for Launching University Life Science Startups (VC / TTO Roundtable, Spring 2020)